Bob Bradway
Chairman and Chief Executive Officer
Replay available
Amgen Inc. (NASDAQ: AMGN) Q4 2025 earnings conference call, held 2026-02-03. Replay captured from the company's public earnings webcast.

Chairman and Chief Executive Officer
President of Research and Development
President of Global Commercial Operations
Executive Vice President and Chief Financial Officer
Analyst, UBS Financial Services
Analyst, TD Cowen
Analyst, Piper Sandler
Analyst, Goldman Sachs
Watch the replay and follow the connected company analysis, news, and investor updates for Amgen Inc..
WEBVTT 00:00:01.280 -- 00:00:05.545 Thank you, Jillian. Good afternoon, everyone, and welcome to our fourth quarter 2025 00:00:05.545 -- 00:00:10.752 earnings call. Bob Bradway will lead the call today and be followed by a broader review 00:00:10.752 -- 00:00:16.238 of our performance by Jay Bradner, Myrto Gordon, and Peter Griffith. 00:00:16.238 -- 00:00:20.444 Through the course of our discussion today, we will use non-GAAP financial measures to 00:00:20.444 -- 00:00:24.228 describe our performance and have provided appropriate reconciliations 00:00:24.228 -- 00:00:27.200 within the materials that accompany this call. 00:00:27.200 -- 00:00:30.785 We will also make some forward-looking statements which are qualified by our safe harbor 00:00:30.785 -- 00:00:34.892 statement, and please note that actual results can vary materially. 00:00:34.892 -- 00:00:36.594 Over to you, Bob. 00:00:36.594 -- 00:00:39.358 Okay. Thank you, Casey, and good afternoon, everyone. 00:00:39.358 -- 00:00:44.726 Thank you for joining us today. Today we'll cover full-year results for 2025 and 00:00:44.726 -- 00:00:48.830 provide a preview of what to expect from us in 2026. 00:00:49.113 -- 00:00:54.121 Amgen delivered strong operational performance across the board in 2025, 00:00:54.121 -- 00:00:57.119 and you can see that in the breadth of our business. 00:00:57.119 -- 00:01:02.044 Note that 14 of our products achieved blockbuster status with sales of a billion dollars 00:01:02.044 -- 00:01:03.826 or more, 13 00:01:03.826 -- 00:01:08.931 products delivered double-digit sales growth, and 18 products achieved record results 00:01:08.931 -- 00:01:14.017 for us. The strength of that broad portfolio enabled us to post double-digit 00:01:14.017 -- 00:01:18.660 growth in revenues and earnings per sha...